Literature DB >> 23303602

Repurposing the Pap smear: one step closer to gynecologic cancer screening.

Shannon N Westin1, Gordon B Mills, Andrea P Myers.   

Abstract

Prevention and early detection remain essential to decreasing cancer mortality. Screening DNA in Pap smears has the potential to increase the rate of early detection of endometrial and ovarian cancers. In this issue of Science Translational Medicine, Kinde and colleagues use advanced sequencing technology to evaluate DNA to screen for gynecologic malignancies.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23303602      PMCID： PMC3824959          DOI： 10.1126/scitranslmed.3005411

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  19 in total

1.  Molecular identification of latent precancers in histologically normal endometrium.

Authors:  G L Mutter; T A Ince; J P Baak; G A Kust; X P Zhou; C Eng
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

Review 2.  Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance.

Authors:  Emmanuelle Gormally; Elodie Caboux; Paolo Vineis; Pierre Hainaut
Journal:  Mutat Res       Date:  2007-01-25       Impact factor: 2.433

Review 3.  Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

Authors:  Marc Arbyn; Christine Bergeron; Paul Klinkhamer; Pierre Martin-Hirsch; Albertus G Siebers; Johan Bulten
Journal:  Obstet Gynecol       Date:  2008-01       Impact factor: 7.661

4.  Cervicovaginal and endometrial cytology in ovarian cancer.

Authors:  T Takashina; M Ono; Y Kanda; S Sagae; O Hayakawa; E Ito
Journal:  Acta Cytol       Date:  1988 Mar-Apr       Impact factor: 2.319

5.  ThinPrep detection of cervical and endometrial adenocarcinoma: a retrospective cohort study.

Authors:  John O Schorge; M Hossein Saboorian; Linda Hynan; Raheela Ashfaq
Journal:  Cancer       Date:  2002-12-25       Impact factor: 6.860

6.  [Principles and practice of mass screening for disease].

Authors:  J M Wilson; Y G Jungner
Journal:  Bol Oficina Sanit Panam       Date:  1968-10

7.  Long-term trends in cancer mortality in the United States, 1930-1998.

Authors:  Phyllis A Wingo; Cheryll J Cardinez; Sarah H Landis; Robert T Greenlee; Lynn A G Ries; Robert N Anderson; Michael J Thun
Journal:  Cancer       Date:  2003-06-15       Impact factor: 6.860

8.  Human papillomavirus and Papanicolaou tests to screen for cervical cancer.

Authors:  Pontus Naucler; Walter Ryd; Sven Törnberg; Anders Strand; Göran Wadell; Kristina Elfgren; Thomas Rådberg; Björn Strander; Bo Johansson; Ola Forslund; Bengt-Göran Hansson; Eva Rylander; Joakim Dillner
Journal:  N Engl J Med       Date:  2007-10-18       Impact factor: 91.245

Review 9.  Prevalence of psammoma bodies in Papanicolaou-stained cervicovaginal smears.

Authors:  S B Kern
Journal:  Acta Cytol       Date:  1991 Jan-Feb       Impact factor: 2.319

10.  Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort.

Authors:  Ian Jacobs; Aleksandra Gentry-Maharaj; Matthew Burnell; Ranjit Manchanda; Naveena Singh; Aarti Sharma; Andy Ryan; Mourad W Seif; Nazar N Amso; Gillian Turner; Carol Brunell; Gwendolen Fletcher; Rani Rangar; Kathy Ford; Keith Godfrey; Alberto Lopes; David Oram; Jonathan Herod; Karin Williamson; Ian Scott; Howard Jenkins; Tim Mould; Robert Woolas; John Murdoch; Stephen Dobbs; Simon Leeson; Derek Cruickshank; Steven J Skates; Lesley Fallowfield; Mahesh Parmar; Stuart Campbell; Usha Menon
Journal:  Lancet Oncol       Date:  2010-12-10       Impact factor: 41.316
View more
  1 in total

1.  The clinical significance of occult gynecologic primary tumours in metastatic cancer.

Authors:  M B Hannouf; E Winquist; S M Mahmud; M Brackstone; S Sarma; G Rodrigues; P K Rogan; J S Hoch; G S Zaric
Journal:  Curr Oncol       Date:  2017-10-25       Impact factor: 3.677
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.